D-Index & Metrics Best Publications
Biology and Biochemistry
Netherlands
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 128 Citations 62,170 371 World Ranking 195 National Ranking 1

Research.com Recognitions

Awards & Achievements

2022 - Research.com Biology and Biochemistry in Netherlands Leader Award

Member of the European Molecular Biology Organization (EMBO)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Enzyme

Peter ten Dijke mostly deals with SMAD, Signal transduction, Cancer research, Cell biology and Transforming growth factor. His SMAD research is multidisciplinary, relying on both R-SMAD, Transcription factor and Hedgehog signaling pathway. His Signal transduction research is multidisciplinary, incorporating elements of Receptor, Phosphorylation and Gefitinib.

His work deals with themes such as Epithelial–mesenchymal transition, Metastasis and Immunology, which intersect with Cancer research. His Cell biology study combines topics from a wide range of disciplines, such as Cellular differentiation, Internal medicine, Bone morphogenetic protein and Endocrinology. The Transforming growth factor study combines topics in areas such as Cancer and Transforming growth factor, beta 3.

His most cited work include:

  • TGF-beta signalling from cell membrane to nucleus through SMAD proteins (3313 citations)
  • TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. (893 citations)
  • TGF-β in progression of liver disease (404 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cell biology, Cancer research, Transforming growth factor, SMAD and Signal transduction. His Cell biology study integrates concerns from other disciplines, such as Receptor, Endocrinology and Bone morphogenetic protein. Peter ten Dijke has included themes like Cancer cell, Cancer, Breast cancer, Metastasis and Transforming growth factor beta in his Cancer research study.

His biological study spans a wide range of topics, including Fibrosis, Extracellular matrix, Transforming growth factor, beta 3 and Cell growth. His work in SMAD tackles topics such as Molecular biology which are related to areas like TGF beta receptor 2. His Signal transduction study incorporates themes from Epithelial–mesenchymal transition, Ubiquitin, Mesenchymal stem cell and Immunology.

He most often published in these fields:

  • Cell biology (47.33%)
  • Cancer research (45.04%)
  • Transforming growth factor (41.22%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (45.04%)
  • Cell biology (47.33%)
  • Transforming growth factor (41.22%)

In recent papers he was focusing on the following fields of study:

Peter ten Dijke focuses on Cancer research, Cell biology, Transforming growth factor, Signal transduction and SMAD. His Cancer research research is multidisciplinary, incorporating elements of Bladder cancer, Cancer, Metastasis, Cancer cell and Transforming growth factor beta. The various areas that Peter ten Dijke examines in his Cell biology study include In vitro, Ubiquitin and Bone morphogenetic protein.

His studies in Transforming growth factor integrate themes in fields like Slug, Regulation of gene expression and Transcription factor. The Signal transduction study combines topics in areas such as Cell, Tissue homeostasis and Mesoderm. He studied SMAD and Crosstalk that intersect with Neuroscience.

Between 2018 and 2021, his most popular works were:

  • TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis (151 citations)
  • Bone morphogenetic protein receptor signal transduction in human disease. (56 citations)
  • The therapeutic potential of targeting the endothelial-to-mesenchymal transition. (37 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Enzyme

His primary areas of study are Cancer research, Signal transduction, Metastasis, Transforming growth factor and Cancer cell. His work deals with themes such as Carcinogenesis, Transforming growth factor beta, Downregulation and upregulation and Bone morphogenetic protein, which intersect with Cancer research. His Signal transduction research is classified as research in Cell biology.

His Cell biology research incorporates themes from Tissue engineering and Angiogenesis. His research investigates the connection between Transforming growth factor and topics such as Cancer that intersect with problems in Immune system, Immunogenicity, Immunology and Blockade. His biological study spans a wide range of topics, including Glycolysis and TGF beta signaling pathway.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

Carl-Henrik Heldin;Kohei Miyazono;Peter ten Dijke.
Nature (1997)

4767 Citations

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata.
The EMBO Journal (1997)

1231 Citations

TGF-β in progression of liver disease

Steven Dooley;Peter ten Dijke.
Cell and Tissue Research (2012)

608 Citations

Signaling inputs converge on nuclear effectors in TGF-β signaling

Peter ten Dijke;Kohei Miyazono;Carl-Henrik Heldin.
Trends in Biochemical Sciences (2000)

509 Citations

Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling

Serhiy Souchelnytskyi;Kiyoshi Tamaki;Ulla Engström;Christer Wernstedt.
Journal of Biological Chemistry (1997)

495 Citations

INDUCTION OF INHIBITORY SMAD6 AND SMAD7 MRNA BY TGF-BETA FAMILY MEMBERS

Mozhgan Afrakhte;Anita Morén;Surinder Jossan;Susumu Itoh.
Biochemical and Biophysical Research Communications (1998)

453 Citations

Signaling by members of the TGF-β family in vascular morphogenesis and disease

Evangelia Pardali;Marie-José Goumans;Peter ten Dijke.
Trends in Cell Biology (2010)

433 Citations

The dynamic roles of TGF‐β in cancer

Erik Meulmeester;Peter ten Dijke;Peter ten Dijke.
The Journal of Pathology (2011)

415 Citations

MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling.

Sidong Huang;Michael Hölzel;Theo Knijnenburg;Andreas Schlicker.
Cell (2012)

392 Citations

The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells

Martine Deckers;Maarten van Dinther;Jeroen Buijs;Ivo Que.
Cancer Research (2006)

390 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter ten Dijke

Kohei Miyazono

Kohei Miyazono

University of Tokyo

Publications: 188

Carl-Henrik Heldin

Carl-Henrik Heldin

Uppsala University

Publications: 91

Aristidis Moustakas

Aristidis Moustakas

Uppsala University

Publications: 74

Takeshi Imamura

Takeshi Imamura

Ehime University

Publications: 68

Carmelo Bernabeu

Carmelo Bernabeu

Spanish National Research Council

Publications: 61

Marie-José Goumans

Marie-José Goumans

Leiden University Medical Center

Publications: 57

Joan Massagué

Joan Massagué

Memorial Sloan Kettering Cancer Center

Publications: 52

Jeffrey L. Wrana

Jeffrey L. Wrana

Lunenfeld-Tanenbaum Research Institute

Publications: 48

Rik Derynck

Rik Derynck

University of California, San Francisco

Publications: 47

Petra Knaus

Petra Knaus

Freie Universität Berlin

Publications: 40

Ye-Guang Chen

Ye-Guang Chen

Tsinghua University

Publications: 40

Anita B. Roberts

Anita B. Roberts

National Institutes of Health

Publications: 39

Susumu Itoh

Susumu Itoh

Showa Pharmaceutical University

Publications: 35

Masahiro Kawabata

Masahiro Kawabata

Japanese Foundation For Cancer Research

Publications: 35

Xin-Hua Feng

Xin-Hua Feng

Life Sciences Institute

Publications: 34

Danny Huylebroeck

Danny Huylebroeck

Erasmus MC

Publications: 33

Trending Scientists

Thomas R. Ioerger

Thomas R. Ioerger

Texas A&M University

Joseph V. Carcello

Joseph V. Carcello

University of Tennessee at Knoxville

Claudio Bianchini

Claudio Bianchini

Sun Yat-sen University

Qian Wang

Qian Wang

University of South Carolina

Lian-Mao Peng

Lian-Mao Peng

Peking University

Kenneth J. Sytsma

Kenneth J. Sytsma

University of Wisconsin–Madison

Willem van Schaik

Willem van Schaik

University of Birmingham

Hikaru Satoh

Hikaru Satoh

Kyushu University

Andrei I. Ivanov

Andrei I. Ivanov

Cleveland Clinic

Lothar Ratschbacher

Lothar Ratschbacher

TU Bergakademie Freiberg

Johannes Zimmermann

Johannes Zimmermann

University of Kassel

Gary S. Sachs

Gary S. Sachs

Harvard University

Gary E. Rosenthal

Gary E. Rosenthal

Wake Forest University

Frank L. Greenway

Frank L. Greenway

Pennington Biomedical Research Center

Donald K. Ingram

Donald K. Ingram

Louisiana State University

Harald Ebeling

Harald Ebeling

University of Hawaii System

Something went wrong. Please try again later.